UniProt ID | F13B_HUMAN | |
---|---|---|
UniProt AC | P05160 | |
Protein Name | Coagulation factor XIII B chain | |
Gene Name | F13B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 661 | |
Subcellular Localization | Secreted . | |
Protein Description | The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin.. | |
Protein Sequence | MRLKNLTFIIILIISGELYAEEKPCGFPHVENGRIAQYYYTFKSFYFPMSIDKKLSFFCLAGYTTESGRQEEQTTCTTEGWSPEPRCFKKCTKPDLSNGYISDVKLLYKIQENMRYGCASGYKTTGGKDEEVVQCLSDGWSSQPTCRKEHETCLAPELYNGNYSTTQKTFKVKDKVQYECATGYYTAGGKKTEEVECLTYGWSLTPKCTKLKCSSLRLIENGYFHPVKQTYEEGDVVQFFCHENYYLSGSDLIQCYNFGWYPESPVCEGRRNRCPPPPLPINSKIQTHSTTYRHGEIVHIECELNFEIHGSAEIRCEDGKWTEPPKCIEGQEKVACEEPPFIENGAANLHSKIYYNGDKVTYACKSGYLLHGSNEITCNRGKWTLPPECVENNENCKHPPVVMNGAVADGILASYATGSSVEYRCNEYYLLRGSKISRCEQGKWSSPPVCLEPCTVNVDYMNRNNIEMKWKYEGKVLHGDLIDFVCKQGYDLSPLTPLSELSVQCNRGEVKYPLCTRKESKGMCTSPPLIKHGVIISSTVDTYENGSSVEYRCFDHHFLEGSREAYCLDGMWTTPPLCLEPCTLSFTEMEKNNLLLKWDFDNRPHILHGEYIEFICRGDTYPAELYITGSILRMQCDRGQLKYPRCIPRQSTLSYQEPLRT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
162 | N-linked_Glycosylation | APELYNGNYSTTQKT CCCCCCCCCCCCEEE | 24.76 | 17623646 | |
162 | N-linked_Glycosylation | APELYNGNYSTTQKT CCCCCCCCCCCCEEE | 24.76 | 17623646 | |
182 | Phosphorylation | KVQYECATGYYTAGG EEEEEEECCEEECCC | 37.06 | - | |
373 | Phosphorylation | SGYLLHGSNEITCNR CCEEECCCCEEECCC | 22.12 | 27130503 | |
377 | Phosphorylation | LHGSNEITCNRGKWT ECCCCEEECCCCCEE | 9.50 | 28270605 | |
512 | Phosphorylation | CNRGEVKYPLCTRKE CCCCCCCCCEECCCC | 13.45 | - | |
516 | O-linked_Glycosylation | EVKYPLCTRKESKGM CCCCCEECCCCCCCC | 53.08 | 30620550 | |
520 | O-linked_Glycosylation | PLCTRKESKGMCTSP CEECCCCCCCCCCCC | 37.23 | 30620550 | |
545 | N-linked_Glycosylation | STVDTYENGSSVEYR CEEEECCCCCCEEEE | 45.28 | 17623646 | |
545 | N-linked_Glycosylation | STVDTYENGSSVEYR CEEEECCCCCCEEEE | 45.28 | 16335952 | |
562 | Phosphorylation | DHHFLEGSREAYCLD CCHHCCCCCEEEEEC | 19.99 | 24505115 | |
643 | Phosphorylation | CDRGQLKYPRCIPRQ ECCCCCCCCCCCCCC | 12.42 | - | |
652 | O-linked_Glycosylation | RCIPRQSTLSYQEPL CCCCCCCCCCCCCCC | 16.04 | OGP | |
661 | Phosphorylation | SYQEPLRT------- CCCCCCCC------- | 51.12 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of F13B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F13B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F13B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FIBG_HUMAN | FGG | physical | 8756701 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613235 | Factor XIII subunit B deficiency (FA13BD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-162, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-545, AND MASSSPECTROMETRY. |